新生儿红细胞输血：修订指南。
Red blood cell transfusions in newborn infants: Revised guidelines.
出版信息
Paediatr Child Health. 2002 Oct;7(8):553-66. doi: 10.1093/pch/7.8.553.
Abstract
In general, health care professionals taking care of high risk infants in neonatal intensive care units have become more restrictive in their use of red blood cell transfusion over the past 10 years. The present statement is intended for those caring for high risk newborn infants (preterm to one month of age). The objectives of this statement are to provide guidelines to reduce the incidence of anemia in preterm and term infants, to identify strategies to decrease the need for red blood cell transfusions and to limit donor exposure in this population. Recommendations for red blood cell transfusions are included.
摘要
总体而言，在过去10年中，在新生儿重症监护病房照顾高危婴儿的医护人员在红细胞输血的使用上变得更加严格。本声明适用于照顾高危新生儿（早产至1月龄）的人员。本声明的目的是提供指导方针，以降低早产和足月婴儿贫血的发生率，确定减少红细胞输血需求的策略，并限制该人群的供体暴露。其中包括红细胞输血的建议。
相似文献
1
Red blood cell transfusions in newborn infants: Revised guidelines.新生儿红细胞输血：修订指南。
Paediatr Child Health. 2002 Oct;7(8):553-66. doi: 10.1093/pch/7.8.553.
2
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期使用促红细胞生成素预防早产和/或低出生体重儿的红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004863. doi: 10.1002/14651858.CD004863.pub2.
3
Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.晚期促红细胞生成素预防早产和/或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004868. doi: 10.1002/14651858.CD004868.pub2.
4
Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期与晚期使用促红细胞生成素预防早产和/或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004865. doi: 10.1002/14651858.CD004865.pub2.
5
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期使用促红细胞生成素预防早产和/或低出生体重儿的红细胞输血。
Cochrane Database Syst Rev. 2012 Sep 12(9):CD004863. doi: 10.1002/14651858.CD004863.pub3.
6
Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.晚期促红细胞生成素预防早产和/或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2014 Apr 23(4):CD004868. doi: 10.1002/14651858.CD004868.pub4.
7
Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants.早产儿红细胞输血宽松与严格指南的随机试验
Pediatrics. 2005 Jun;115(6):1685-91. doi: 10.1542/peds.2004-1884.
8
Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.晚期促红细胞生成素预防早产和/或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2012 Sep 12(9):CD004868. doi: 10.1002/14651858.CD004868.pub3.
9
Effects of blood sampling stewardship and erythropoietin administration in extremely low birth weight infants-a quality improvement non-controlled before-and-after retrospective study.极低出生体重儿的采血管理和促红细胞生成素应用效果：一项质量改进的非对照前后回顾性研究。
Eur J Pediatr. 2021 May;180(5):1617-1626. doi: 10.1007/s00431-020-03925-9. Epub 2021 Jan 19.
10
Updates in Red Blood Cell and Platelet Transfusions in Preterm Neonates.早产儿红细胞和血小板输注的更新。
Am J Perinatol. 2019 Jul;36(S 02):S37-S40. doi: 10.1055/s-0039-1691775. Epub 2019 Jun 25.
引用本文的文献
1
Retrospective cohort study of neonatal blood transfusion in China.中国新生儿输血的回顾性队列研究。
BMC Pediatr. 2023 Dec 9;23(1):621. doi: 10.1186/s12887-023-04225-5.
2
Evidence-Based Guidelines for Acute Stabilization and Management of Neonates with Persistent Pulmonary Hypertension of the Newborn.证据为基础的指南：新生儿持续肺动脉高压的急性稳定化和管理。
Am J Perinatol. 2023 Oct;40(14):1495-1508. doi: 10.1055/a-1711-0778. Epub 2021 Dec 1.
3
Transfusion rates and disease spectrum in neonates treated with blood transfusion in China.中国接受输血治疗的新生儿的输血率和疾病谱
Medicine (Baltimore). 2020 May;99(18):e19961. doi: 10.1097/MD.0000000000019961.
4
Transfusion support in preterm neonates <1500 g and/or <32 weeks in a tertiary care center: A descriptive study.三级护理中心中体重<1500克和/或孕周<32周的早产儿的输血支持：一项描述性研究。
Asian J Transfus Sci. 2018 Jan-Jun;12(1):34-41. doi: 10.4103/ajts.AJTS_148_16.
5
Red blood cell transfusion in newborn infants.新生儿红细胞输血
Paediatr Child Health. 2014 Apr;19(4):213-22. doi: 10.1093/pch/19.4.213.
6
Transfusion and risk of infection in Canada: Update 2012.加拿大的输血与感染风险：2012年更新
Paediatr Child Health. 2012 Dec;17(10):e102-6. doi: 10.1093/pch/17.10.e102.
7
Gentamicin in neonates at risk for sepsis - peak serum concentrations are not necessary.对于有败血症风险的新生儿，庆大霉素——血清峰值浓度并非必要。
Paediatr Child Health. 2012 Jun;17(6):310-2.
8
Nonpharmacological, blood conservation techniques for preventing neonatal anemia--effective and promising strategies for reducing transfusion.非药物性、血液保护技术预防新生儿贫血——减少输血的有效且有前途的策略。
Semin Perinatol. 2012 Aug;36(4):232-43. doi: 10.1053/j.semperi.2012.04.003.
9
Transfusion and risk of infection in Canada: Update 2006.加拿大的输血与感染风险：2006年更新
Can J Infect Dis Med Microbiol. 2006 Mar;17(2):103-7.
本文引用的文献
1
Effectiveness of WBC reduction in neonates: what is the evidence of benefit?
Transfusion. 2002 Feb;42(2):159-65. doi: 10.1046/j.1537-2995.2002.00022.x.
2
Current best evidence: a review of the literature on umbilical cord clamping.当前最佳证据：关于脐带结扎的文献综述
J Midwifery Womens Health. 2001 Nov-Dec;46(6):402-14. doi: 10.1016/s1526-9523(01)00196-9.
3
Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial.早期促红细胞生成素治疗对出生体重低于1250克的早产儿输血需求的影响：一项多中心、随机、对照试验。
Pediatrics. 2001 Oct;108(4):934-42. doi: 10.1542/peds.108.4.934.
4
Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity.
Transfusion. 2001 Mar;41(3):406-15. doi: 10.1046/j.1537-2995.2001.41030406.x.
5
Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?在严格输血指南下对极低和超低出生体重儿进行红细胞输血：外源性促红细胞生成素是否必要？
Arch Dis Child Fetal Neonatal Ed. 2001 Mar;84(2):F96-F100. doi: 10.1136/fn.84.2.f96.
6
Randomized trial assessing the feasibility and safety of biologic parents as RBC donors for their preterm infants.评估亲生父母作为其早产儿红细胞供体的可行性和安全性的随机试验。
Transfusion. 2000 Apr;40(4):450-6. doi: 10.1046/j.1537-2995.2000.40040450.x.
7
Transfusion associated graft-versus-host disease, cytomegalovirus infection and HLA alloimmunization in neonatal and pediatric patients.新生儿和儿科患者的输血相关移植物抗宿主病、巨细胞病毒感染及人类白细胞抗原同种免疫
Transfus Sci. 1999 Aug;21(1):73-95. doi: 10.1016/s0955-3886(99)00067-3.
8
Blood banking issues pertaining to neonatal red blood cell transfusions.与新生儿红细胞输血相关的血液储备问题。
Transfus Sci. 1999 Aug;21(1):7-19. doi: 10.1016/s0955-3886(99)00063-6.
9
Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g.出生体重低于1000克婴儿红细胞输血实践的改变
J Pediatr. 2000 Feb;136(2):220-4. doi: 10.1016/s0022-3476(00)70105-3.
10
Feasibility and safety of AS-3 red blood cells for neonatal transfusions.用于新生儿输血的AS-3红细胞的可行性和安全性。
J Pediatr. 2000 Feb;136(2):215-9. doi: 10.1016/s0022-3476(00)70104-1.
Zotero 插件